G Pappagallo
Overview
Explore the profile of G Pappagallo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barni S, Lorusso V, Giordano M, Sogno G, Gamucci T, Santoro A, et al.
Med Oncol
. 2013 Dec;
31(1):797.
PMID: 24307348
Febrile neutropenia (FN) is a severe dose-limiting side effect of myelosuppressive chemotherapy in patients with solid tumors. Clinical practice guidelines recommend primary prophylaxis with G-CSF in patients with an overall...
2.
Iaffaioli R, Formato R, Tortoriello A, Del Prete S, Caraglia M, Pappagallo G, et al.
Br J Cancer
. 2005 Apr;
92(9):1621-5.
PMID: 15856035
Hormonal therapy is the preferred systemic treatment for recurrent or metastatic, post-menopausal hormone-receptor-positive breast cancer. Previous studies have shown that there is no cross-resistance between exemestane and reversible aromatase inhibitors....
3.
Siracusano S, Tomasi P, Pecorari V, dAloia G, Stener S, Pappagallo G
Scand J Urol Nephrol
. 2002 May;
36(1):25-7.
PMID: 12002353
Objective: To assess the existence of a vesical hypothalamic reflex by evaluating the changes of plasmatic ADH levels during acute bladder filling in healthy adult volunteers. Materials And Methods: Twenty...
4.
Bassi P, Iafrate M, Spinadin R, Carando R, Iannello R, Repele M, et al.
Arch Ital Urol Androl
. 2002 Feb;
73(4):181-6.
PMID: 11822064
Purpose: The appropriate treatment of superficial bladder neoplasm is still debated. The urologist must weigh the risk of tumor recurrence and progression against the possible side effects of conservative treatment...
5.
Bassi P, Ferrante G, Piazza N, Spinadin R, Carando R, Pappagallo G, et al.
J Urol
. 1999 Apr;
161(5):1494-7.
PMID: 10210380
Purpose: Pathological predictors of outcome for patients undergoing radical cystectomy for bladder cancer are needed as few data are available in the literature. We retrospectively analyzed a homogeneous and contemporary...
6.
Dittadi R, Brazzale A, Pappagallo G, Salbe C, Nascimben O, Rosabian A, et al.
Anticancer Res
. 1997 Mar;
17(2B):1245-7.
PMID: 9137481
ErbB2/neu protein (p185) expression was evaluated by ELISA in 115 breast cancer specimens. Distribution was subdivided in quartiles and showed a distinct behaviour in comparison with both clinico-biological parameters and...
7.
Paccagnella A, Favaretto A, Riccardi A, Danova M, Ghiotto C, Giordano M, et al.
Cancer
. 1993 Aug;
72(3):697-706.
PMID: 8392903
Background: Until now, no dose-response correlation has been clearly defined in small cell lung cancer (SCLC). Methods: Forty-one consecutive patients with SCLC entered this study, 21 (limited [L]/extensive [E] =...
8.
Pagano F, Dal Bianco M, Artibani W, Pappagallo G, Prayer Galetti T
Eur Urol
. 1992 Jan;
22(3):200-3.
PMID: 1468475
Management of renal cell carcinoma with extension into the vena cava is one of the highest challenges in urology. The delineation of the upper level of the endocaval thrombus, its...
9.
Giunta G, Pappagallo G, Piazza I, Girardi A
Minerva Med
. 1990 Jul;
81(7-8):577-81.
PMID: 2381556
Intranasal meningoencephalocele is a rare malformation characterized by a protrusion of brain tissue and meninges out of the cranial cavity into the nose, through a discontinuity of the ethmoidal cribriform...
10.
Paccagnella A, Favaretto A, Brandes A, Ghiotto C, Fornasiero A, Volpi A, et al.
Cancer
. 1990 Jun;
65(12):2631-4.
PMID: 2160312
A Phase II randomized study testing the combination of cisplatin, etoposide, and ifosfamide (PEI) in non-small cell lung cancer (NSCLC) was performed. The standard combination of cisplatin and etoposide (PE)...